Literature DB >> 17276944

Mitotic rate in melanoma: a reexamination.

Maria Gallego Attis1, Robin T Vollmer.   

Abstract

We reexamined the relationship between mitotic rate and overall survival in more than 1,200 cases of cutaneous melanoma with long-term follow-up. Like others, we found that mitotic rate was significantly associated with survival (P < 4 x 10(-8)) and more prognostic than tumor ulceration but was not an independent prognosticator because it was significantly associated with tumor thickness and ulceration. Thus, all 3 histologic variables are interrelated; among these, tumor thickness is the most important. Although mitotic rate can be effectively categorized in 3 groups (1/mm2, 1/mm2(-4)/mm2, and > 4/mm2), the optimal way to use mitotic rate remains unclear, and even this simplification requires determining the raw number per square millimeter. Because the collective information provided by tumor thickness, mitotic rate, ulceration, patient age, and site of tumor about hard outcomes such as 5-year fatality is limited and because measuring mitotic rate requires extra time, we recommend that mitotic rate need not be part of routine reports on cutaneous melanoma. Nevertheless, mitotic rate should continued to be measured in academic centers and other sites that maintain large prospective databases on melanoma, and it should be included in further studies of prognosis and adjuvant therapies for cutaneous melanoma.

Entities:  

Mesh:

Year:  2007        PMID: 17276944     DOI: 10.1309/LB7RTC61B7LC6HJ6

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Authors:  John F Thompson; Seng-Jaw Soong; Charles M Balch; Jeffrey E Gershenwald; Shouluan Ding; Daniel G Coit; Keith T Flaherty; Phyllis A Gimotty; Timothy Johnson; Marcella M Johnson; Stanley P Leong; Merrick I Ross; David R Byrd; Natale Cascinelli; Alistair J Cochran; Alexander M Eggermont; Kelly M McMasters; Martin C Mihm; Donald L Morton; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Authors:  Jerzy Lasota; Artur Kowalik; Anna Felisiak-Golabek; Sebastian Zięba; Piotr Waloszczyk; Marek Masiuk; Jaroslaw Wejman; Justyna Szumilo; Markku Miettinen
Journal:  Mod Pathol       Date:  2019-02-13       Impact factor: 7.842

Review 3.  Epidemiology and treatment of melanoma in elderly patients.

Authors:  Susan Tsai; Charles Balch; Julie Lange
Journal:  Nat Rev Clin Oncol       Date:  2010-02-09       Impact factor: 66.675

4.  Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.

Authors:  Christopher S Hale; Meng Qian; Michelle W Ma; Patrick Scanlon; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Yongzhao Shao; David Polsky; Iman Osman; Farbod Darvishian
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

5.  [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].

Authors:  H Bösmüller; S Haitchi-Petnehazy; T Hintringer; T Mentzel
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

6.  Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Authors:  Rita G Ladstein; Ingeborg M Bachmann; Oddbjørn Straume; Lars A Akslen
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

7.  Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.

Authors:  Dusan Bogunovic; David W O'Neill; Ilana Belitskaya-Levy; Vladimir Vacic; Yi-Lo Yu; Sylvia Adams; Farbod Darvishian; Russell Berman; Richard Shapiro; Anna C Pavlick; Stefano Lonardi; Jiri Zavadil; Iman Osman; Nina Bhardwaj
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

8.  Thigmotropism of malignant melanoma cells.

Authors:  Pascale Quatresooz; Claudine Piérard-Franchimont; Fanchon Noël; Gérald E Piérard
Journal:  Dermatol Res Pract       Date:  2011-11-17

9.  Smouldering malignant melanoma and metastatic dormancy: an update and review.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Marie-Annick Reginster; Pascale Quatresooz
Journal:  Dermatol Res Pract       Date:  2011-11-02

Review 10.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.